Omega Healthcare Investors Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $908.4M | $900.8M | $743.6M | $504.8M | $418.7M | $350.5M | $292.2M | $258.3M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $47.7M | $45.9M | $38.6M | $25.9M | $21.6M | $21.3M | $19.4M | $15.1M |
| Operating Income | $315.2M | $560.0M | $411.3M | $345.3M | $265.7M | $215.0M | $137.8M | $148.9M |
| Operating Margin | 34.7% | 62.2% | 55.3% | 68.4% | 63.5% | 61.3% | 47.2% | 57.7% |
| Interest Expense | $188.8M | $164.1M | $147.4M | $119.4M | $100.4M | $95.5M | $81.2M | $67.3M |
| Pretax Income | $105.9M | $384.3M | $234.5M | $221.3M | $172.5M | — | — | $58.4M |
| Income Tax Expense | $3.2M | $1.4M | $1.2M | — | — | — | — | $0 |
| Net Income | $104.9M | $383.4M | $233.3M | $221.3M | $172.5M | $120.7M | $52.6M | $58.4M |
| Net Margin | 11.5% | 42.6% | 31.4% | 43.8% | 41.2% | 34.4% | 18.0% | 22.6% |
| EPS (Basic) | $0.51 | $1.91 | $1.30 | $1.75 | $1.47 | $1.12 | $0.46 | $0.52 |
| EPS (Diluted) | $0.51 | $1.90 | $1.29 | $1.74 | $1.46 | $1.12 | $0.46 | $0.52 |
| Shares Outstanding (Basic) | 197.7M | 191.8M | 172.2M | 126.6M | 117.3M | 107.6M | 102.1M | 94.1M |
| Shares Outstanding (Diluted) | 206.8M | 201.6M | 180.5M | 127.3M | 118.1M | 108.0M | 102.2M | 94.2M |
| Dividends Per Share | $2.54 | $2.36 | $2.18 | $2.02 | $1.86 | $1.69 | $1.55 | $1.37 |